Friday, September 27, 2013 12:06:29 PM
I agree completely but was told (not by Peregrine) that under such Federal Authorities and investigations that Peregrine Pharmaceuticals can't speak of the details of the investigation.
What can be done next? Everyone has seen the As The World .. or Fargo Turns Posts.... re: ex-Gov Hoeven and now Senator Hoeven and Senator Hoeven can make a difference if he really believes that "patients deserve best."
For instance, he is associated with the FDA committee in the Senate:
"This committee is tasked with writing the legislation that allocates federal funds to the numerous government agencies, departments, and organizations on an annual basis. Once the annual funding levels are set by the Senate Budget Committee, the Appropriations Committee works to ensure that important projects and services are appropriately funded."
http://www.hoeven.senate.gov/public/index.cfm/committee-assignments
---------------------------------------------------------------
He knows which companies were granted funds and which ones requested money and were denied. Senator Hoeven also knows very well of Fargo like trial affairs and wouldn't a Senator with a such a biotech presence back home in Fargo be part of taking the initiative of writing a bill that "protects" the people during clinical trials ?? and don't fall trap to the same mistakes that other politicians make and try and cover up mistakes and protects only those agenda driven.
I know many Senators can be lobbied by business to protect big business.... but its the people who vote him in and Fargo issues will not go away. Peregrine Pharmaceuticals was one small biotech trying to give what "patients deserve best" and sometimes business and lobbyists are not out for the patients.
Senator Hoeven has been rumored to run in 2016 and my guess is imagine IF Peregrine is at center stage at that time with the anti-PS platform and Senator Hoeven was on their side assisting them in their progress. Ironically.... how many people are affected by cancer that would vote for someone based on their continued support in a drug platform that made a difference in a loved ones life? Thats a vote for a lifetime... though could go in a vote "aye" or vote "nay". Time will tell how that turns out...
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 08:45:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2024 11:40:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:38:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:38:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:37:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 12:22:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 12:21:22 AM
- Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference • GlobeNewswire Inc. • 09/12/2024 08:05:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/09/2024 08:43:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:19:30 PM
- Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 • GlobeNewswire Inc. • 09/09/2024 08:05:31 PM
- U.S. Futures Rise Amid Inflation Report Anticipation; Oil Prices Climb on Hurricane Threat and Supply Concerns • IH Market News • 09/09/2024 10:09:14 AM
- Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024 • GlobeNewswire Inc. • 09/03/2024 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 08:30:10 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/28/2024 08:34:04 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/28/2024 08:32:18 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/28/2024 08:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:50:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:48:19 PM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM
Future Hospitality Ventures Unveils Bold, New AI-Driven Initiative to Revolutionize the $300 Billion Hospitality Market • NGTF • Oct 16, 2024 7:07 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM